| 000 | 01776 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517215022.0 | ||
| 264 | 0 | _c20180914 | |
| 008 | 201809s 0 0 eng d | ||
| 022 | _a2314-7156 | ||
| 024 | 7 |
_a10.1155/2018/9646209 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBasile, Umberto | |
| 245 | 0 | 0 |
_aSerological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients. _h[electronic resource] |
| 260 |
_bJournal of immunology research _c2018 |
||
| 300 |
_a9646209 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAutoantibodies _xmetabolism |
| 650 | 0 | 4 | _aAutoimmunity |
| 650 | 0 | 4 |
_aB-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aBiomarkers, Pharmacological _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin Light Chains _xblood |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyasthenia Gravis _xdiagnosis |
| 650 | 0 | 4 |
_aNeuromuscular Junction _xdrug effects |
| 650 | 0 | 4 |
_aReceptor Protein-Tyrosine Kinases _ximmunology |
| 650 | 0 | 4 |
_aReceptors, Cholinergic _ximmunology |
| 650 | 0 | 4 |
_aReceptors, Nicotinic _ximmunology |
| 650 | 0 | 4 |
_aRituximab _xtherapeutic use |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aMarino, Mariapaola | |
| 700 | 1 | _aNapodano, Cecilia | |
| 700 | 1 | _aPocino, Krizia | |
| 700 | 1 | _aAlboini, Paolo Emilio | |
| 700 | 1 | _aGulli, Francesca | |
| 700 | 1 | _aEvoli, Amelia | |
| 700 | 1 | _aProvenzano, Carlo | |
| 700 | 1 | _aBartoccioni, Emanuela | |
| 773 | 0 |
_tJournal of immunology research _gvol. 2018 _gp. 9646209 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1155/2018/9646209 _zAvailable from publisher's website |
| 999 |
_c28395805 _d28395805 |
||